Journal list Promote Sponsor
verified SJR 0,915 · Q2 • database Scopus / SJR & Web of Science indexed
Expert Review of Endocrinology and Metabolism
United Kingdom · Taylor and Francis Ltd.
workspace_premium Q2 — Endocrinology, Diabetes and Metabolism lock Subscription

Expert Review of Endocrinology and Metabolism

Expert Review of Endocrinology and Metabolism is a journal indexed in SJR in Endocrinology, Diabetes and Metabolism with an H index of 39. It has a price of 4000 €. It has an SJR impact factor of 0,915 and it has a best quartile of Q2. It has an SJR impact factor of 0,915.

ISSN: 1744-6651
Publisher: Taylor and Francis Ltd.
Category: Endocrinology, Diabetes and Metabolism
Indexation: verifiedScopus / SJR verifiedWeb of Science
open_in_new Portal NPD menu_book Guidelines NPD
schedule CountryOfPapers database fields
SJR Impact Factor trending_up
0,915 Q2
H-index 39
Acceptance rate pie_chart
36%
Source Acceptance_Rate
Time to publication hourglass_top
NPD
Field NPD
Publication cost (APC) payments
4.000 € Subscription
Non-OA path 0 €

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR Web of Science

SJR Impact

0,915

H-index

39

Docs (year)

54

Docs 3y

130

Total refs

4189

Cites 3y

384

Citable 3y

121

Cites/Doc 2y

2.95

Ref/Doc

77.57

Immediate OA

4000 €

Embargoed OA

NPD

Non OA / Submission

0 €

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims
rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.
User
* Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Colesevelam: an improved bile acid sequestrant for treating hypercholesterolemia and improving diabetes

View more

Velaglucerase alfa as a therapeutic option for Gaucher disease

View more

Examining the evidence for self-monitoring of blood glucose in non-insulin Type 2 diabetes

View more

Evaluation and management of ketosis-prone diabetes

View more

Estrogen and cognitive functions

View more

Endocrinopathy of HFE-related hemochromatosis

View more

Endocrine regulation of prostate cancer growth

View more

Endocrine function of adipose tissue and its clinical use: still waiting for the prime time?

View more

Endocrine and inflammatory alterations in post-traumatic stress disorder

View more

Effect of nutrition and physical activity on bone health of children and young adults

View more

Diabetes mellitus and prostate cancer risk

View more

Cytochrome P450 1A1: is it involved in disruption of thyroid hormone action by polychlorinated biphenyl?

View more
SHOW MORE ARTICLES

Current strategies and perspectives in insulin gene therapy for diabetes

View more

A multidisciplinary approach to understanding skeletal dysplasias

View more

Clinically meaningful end points in the evolving treatment paradigm for radioactive iodine-refractory differentiated thyroid cancer

View more

Clinical overview of saxagliptin for Type 2 diabetes management

View more

Cardiovascular complications of diabetes: recent insights in pathophysiology and therapeutics

View more

Brain regional thyroid hormone status and Dio3: where genetics, epigenetics and psychiatric vulnerability meet

View more

Bilirubin, cardiovascular diseases and cancer: epidemiological perspectives

View more

Anti-inflammatory effects of gastric bypass surgery and their association with improvement in metabolic profile

View more

An update on diabetes related skeletal fragility

View more

An individualized approach to the child with thyroid cancer

View more

Albiglutide for the management of type 2 diabetes

View more

Adrenal glucocorticoids as a target for jet lag therapies

View more

FAQs